Clinical Trial Update: Gefitinib and Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III or Stage IV Head and Neck Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial assessing gefitinib with radiation therapy, with or without cisplatin, for Stage III or Stage IV head and neck squamous cell carcinoma. The trial …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Squamous Cell Carcinoma of the Hypopharynx
• Squamous Cell Carcinoma of the Larynx
• Squamous Cell Carcinoma of the Lip and Oral Cavity
• Squamous Cell Carcinoma of the Oropharynx

Drugs mentioned

• CISPLATIN (cisplatin)
• Gefitinib (Gefitinib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Stage III Squamous Cell Carcinoma of the Hypopharynx, Stage III Squamous Cell Carcinoma of the Larynx | Phase 1 | Status: TERMINATED